DAWN
Day One Biopharmaceuticals Inc

1,879
Mkt Cap
$977.77M
Volume
1.23M
52W High
$13.53
52W Low
$5.64
PE Ratio
-6.02
DAWN Fundamentals
Price
$9.20
Prev Close
$9.25
Open
$9.34
50D MA
$8.82
Beta
1.13
Avg. Volume
2.73M
EPS (Annual)
-$1.02
P/B
2.04
Rev/Employee
$724,646.41
Loading...
Loading...
News
all
press releases
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN - Get Free Report) have been given an average rating of "Moderate Buy" by the nine analysts that are covering the firm, Marketbeat.com reports...
MarketBeat·10d ago
News Placeholder
More News
News Placeholder
Notable Friday Option Activity: DAWN, XPO, UUUU
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Day One Biopharmaceuticals Inc (Symbol: DAWN), where a total volume of 13,188...
Nasdaq News: Markets·23d ago
News Placeholder
Day One Biopharmaceuticals (NASDAQ:DAWN) Trading Up 5.5% - Still a Buy?
Day One Biopharmaceuticals (NASDAQ:DAWN) Stock Price Up 5.5% - Time to Buy...
MarketBeat·25d ago
News Placeholder
Day One Biopharmaceuticals Target of Unusually Large Options Trading (NASDAQ:DAWN)
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN - Get Free Report) was the recipient of unusually large options trading on Wednesday. Traders purchased 5,027 call options on the stock. This represents...
MarketBeat·25d ago
News Placeholder
Braidwell LP Has $14.18 Million Position in Day One Biopharmaceuticals, Inc. $DAWN
Braidwell LP reduced its position in shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN - Free Report) by 38.3% during the second quarter, according to the company in its most recent 13F filing...
MarketBeat·30d ago
News Placeholder
Day One Biopharmaceuticals (NASDAQ:DAWN) Stock Price Down 4.9% - What's Next?
Day One Biopharmaceuticals (NASDAQ:DAWN) Trading Down 4.9% - Should You Sell...
MarketBeat·1mo ago
News Placeholder
Day One Biopharmaceuticals (NASDAQ:DAWN) Sees Large Volume Increase - Time to Buy?
Day One Biopharmaceuticals (NASDAQ:DAWN) Sees Large Volume Increase - Time to Buy...
MarketBeat·1mo ago
News Placeholder
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Receives Average Recommendation of "Moderate Buy" from Analysts
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN - Get Free Report) has earned a consensus rating of "Moderate Buy" from the nine brokerages that are presently covering the company, Marketbeat Ratings...
MarketBeat·1mo ago
News Placeholder
180,133 Shares in Day One Biopharmaceuticals, Inc. $DAWN Bought by Schroder Investment Management Group
Schroder Investment Management Group acquired a new stake in shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN - Free Report) during the second quarter, according to its most recent Form 13F...
MarketBeat·1mo ago
News Placeholder
Day One Biopharmaceuticals, Inc. $DAWN Shares Purchased by Geode Capital Management LLC
Geode Capital Management LLC boosted its position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN - Free Report) by 11.2% during the second quarter, according to the company in its most recent...
MarketBeat·1mo ago
<
1
2
...
>

Latest DAWN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.